Evidence map›Paper›PMID 32647374›Full record

ArticleScientific reports2020

Natural and engineered chemokine (C-X-C motif) receptor 4 agonists prevent acute respiratory distress syndrome after lung ischemia-reperfusion injury and hemorrhage.

Favin S Babu, Xiaomei Liang, Garrett A Enten, Anthony J DeSantis, Brian F Volkman, Xianlong Gao, Matthias Majetschak

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Favin S BabuDepartment of Surgery, Burn and Shock Trauma Research Institute, Loyola University Chicago, Maywood, IL, USA.
Xiaomei LiangDepartment of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Garrett A EntenDepartment of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Anthony J DeSantisDepartment of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Brian F VolkmanDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA.
Xianlong GaoDepartment of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Matthias MajetschakDepartment of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL, USA. majetschak@usf.edu.
University of South Florida · USLoyola University Chicago · USMedical College of Wisconsin · US

Funding

TRAINING IN TRAUMA AND BURN RESEARCHT32GM008750 · NIGMS · LOYOLA UNIVERSITY CHICAGO · PI CHOUDHRY, MASHKOOR A, GONZALEZ, RICHARD PAUL · 2000 to 2023
$2.9M
Chemokine control of cardiovascular function during hemorrhagic shockR01GM107495 · NIGMS · UNIVERSITY OF SOUTH FLORIDA · PI MAJETSCHAK, MATTHIAS · 2014 to 2017
$1.1M
NIGMS NIH HHS R01 GM107495NIGMS NIH HHS T32 GM008750NIH HHS R01GM107495
6 · The paper itself

Abstract

We compared therapeutic properties of natural and engineered chemokine (C-X-C motif) receptor 4 (CXCR4) agonists in a rat acute respiratory distress syndrome (ARDS) model utilizing the PaO

Indexed as

AnimalsChemokine CXCL12Disease Models, AnimalFluid TherapyHumansLungMaleProtein EngineeringRatsReceptors, CXCR4Reperfusion InjuryRespiratory Distress SyndromeResuscitationShock, HemorrhagicThoracotomyUbiquitinChemokine CXCL12Receptors, CXCR4Ubiquitin

Identifiers

PMID32647374
PMCPMC7347544
OpenAlexW3040974190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.